Prostate-specific antigen: Molecular forms and the human kallikrein gene family

British Journal of Urology

Volumn 79, Issue SUPPL. 1, 1997, Pages 44-48

  Lilja, H ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; PROTEINASE INHIBITOR;

CONFERENCE PAPER; CROSS REACTION; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; MALE; MULTIGENE FAMILY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN STABILITY;

HUMANS; IMMUNOASSAY; KALLIKREINS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS;

EID: 0031401066     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410x.1997.tb00800.x     Document Type: Article

References (41)

1. Ahlgren G, Rannevik G. Lilja H. Impaired secretory function of the prostate in men with oligo-astenozoospermia. J Androl 1995; 16: 491-8
2. Papsidero LD, Kuriyama M. Wang MC et al. Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst 1981; 48: 1229
3. Lilja H. Abrahamsson P-A. Three predominant proteins secreted by the human prostate gland. Prostate 1988; 12: 29-38
4. Clements J, Mukhtar A. Glandular kallikreins and prostatespecific antigen are expressed in the human endometrium. Clin Endocrinol Metab 1994: 78: 1536-9
5. Kamoshida S. Tsutsumi Y. Extraprostatic localisation of prostatic acid phosphatase and prostate-specific antigen: distribution in cloacogenic glandular epithelium and sexdependent expression in human anal gland. Hum Pathol 1990; 21: 1108-11
6. Yu H, Diamandis EP. Prostate-specific antigen in milk of lactating women. Clin Chem 1995: 41: 54-8
7. Yu H. et al Oral contraceptive-induced expression of prostate specific antigen in the female breast. J Biol Chem 1995: 270: 6615-8
8. Yu H, Diamandis EP. Prostate-specific antigen immunoreactivity in amniotic fluid. Clin Chem 1995; 41: 204-10
9. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985; 76: 1899-903
10. Lundwall A, Lilja H. Molecular cloning of human prostate specific antigen cDNA. FEES Lett 1987; 214: 317-22
11. Schaller J, Akiyama K, Tsuda R et al. Isolation, characterisation and amino-acid sequence of gamma-seminoprotein, a glycoprotein from human seminal plasma. Eur J Biochem 1987; 170: 111-20
12. Watt K, Lee P-J, M'Timkulu T et al. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Nat Acad Sei USA 1986; 83: 3166-70
13. Akiyama K, Nakamura T, Iwanaga S et al. The chymotrypsin-like activity of human prostate-specific antigen, g-seminoprotein. FEBS Lett 1987; 225: 168-72
14. Christensson A, Laurell C-B, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990; 194: 755-63
15. Lilja H, Abrahamsson P-A, Lundwall A. Semenogelin, the predominant protein in human semen. J Biol Chem 1989; 264: 1894-900
16. McCormack RT, Rittenhouse HG, Finlay JA et al. Molecular forms of prostate-specific antigen (PSA) and the human kallikrein gene family: a new era. Urology 1995; 45: 729-44
17. Christensson A, Lilja H. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur J Biochem 1994; 220: 45-53
18. Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H. Protein C inhibitor in human body fluids; seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 1992; 89: 1094-101
19. Stenman UH, Leinonen J, Alfthan H et al. A complex between prostate-specific antigen and alpha- 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51: 222-6
20. Lilja H, Christensson A, Dahlén U et al Prostate-specific antigen in human serum occurs predominantly in complex with al-antichymotrypsin. Clin Chem 1991; 37: 1618-25
21. Pettersson K, Piironen T, Seppälä M et al. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-al-antichymotrypsin complex. Clin Chem 1995; 41: 1480-8
22. Villoutreix BO, Lilja H. Pettersson K, Lövgren T, Teleman O. Structural investigation of the alpha-1-antichymotrypsin: prostate specific antigen complex by comparative model building. Protein Sei 1996; 5: 836-51
23. Leinonen J, Zhang W-M, Stenman U-H. Complex formation between PSA isoenzymes and protease inhibitors. J Urol 1996; 155: 1099-103
24. Jacobsen SJ, Lilja H, KLee GG, Wright GLJr, Pettersson K, Oesterling JE. Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigen. Urology 1994; 44: 512-18
25. Christensson A, Björk T, Nilsson O et al. Serum prostatespecific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100-5
26. Lövgren J, Piironen T, Overmo C et al. Production of recombinant PSA and hK2 and analysis of their immunologie crossreactivity. Biochem Biophys Res Commun 1995; 213: 888-95
27. Piironen T, Lövgren J, Karp M et al. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. Clin Chem 1996; 42: 1034-41
28. Heidtmann H-H, Havemann K. Assay of complexed alpha1-antichymotrypsin complexes in serum. Eur J Clin Chem Clin Biochem 1993; 39: 869-74
29. Riegman PH, Vlietstra RJ, Suurmeij L et al. Characterisation of the human kallikrein locus. Genomics 1992; 14: 6-11
30. Chapdelaine P, Paradis G, Tremblay RR, Dube JY. High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen. FEES Lett 1988; 236: 205-8
31. Morris BJ. h.GK-1: A kallikrein gene expressed in human prostate. Clin Exp Pharmacol Physiol 1989; 16: 345-51
32. Young C-F, Andrews PE, Montgomery BT, Tindall DJ. Tissuespecific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry 1992; 31: 818-24
33. Young C-F, Andrews PE, Tindall DJ. Expression and androgenic regulation of human prostate-specific kallikreins. J Andrology 1995; 16: 97-9
34. Schedlich LJ, Bennetts B, Morris BJ. Primary structure of a human glandular kallikrein gene. DNA 1987; 6: 429-37
35. Björk T, Piironen T, Pettersson K et al. Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer. Urology 1997, in press
36. Bjartell A, Björk T, Matikainen MT et al. Production of alpha-1-antichymotrypsin by PSA-containing cells of the human prostate epithelium. Urology 1993; 42: 502-10
37. Björk T, Bjartell A, Abrahamsson PA, Hulkko S, diSant'Agnese A, Lilja H. Alpha-1-antichymotrypsin production in PSA producing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology 1994; 43: 427-34
38. Catalona WJ, Smith DS, Wolfert RL et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995; 274: 1214-20
39. Luderer AA, Chen Y-T, Soriano TF et al. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urol 1995; 46: 187-94
40. Prestigiacomo AF, Lilja H, Pettersson K, Wolfert RL, Stamey TA. A comparison of the 'free' fraction of serum prostate specific antigen (PSA) in men with benign and cancerous prostates. J Urol 1996; 156: 350-4
41. Mitrunen K, Pettersson K, Piironen T, Björk T, Lilja H, Lövgren T. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. Clin Chem 1995:41: 1115-20